Theo Rispens
Theo Rispens
Sanquin Research, University of Amsterdam
Verified email at
Cited by
Cited by
IgG subclasses and allotypes: from structure to effector functions
G Vidarsson, G Dekkers, T Rispens
Frontiers in immunology 5, 520, 2014
Immunoglobulin G4: an odd antibody
RC Aalberse, SO Stapel, J Schuurman, T Rispens
Clinical & Experimental Allergy 39 (4), 469-477, 2009
Immunogenicity of anti-TNF biologic therapies for rheumatoid arthritis
PA Van Schouwenburg, T Rispens, GJ Wolbink
Nature Reviews Rheumatology 9 (3), 164-172, 2013
Loss of infliximab into feces is associated with lack of response to therapy in patients with severe ulcerative colitis
JF Brandse, GR van den Brink, ME Wildenberg, D van der Kleij, ...
Gastroenterology 149 (2), 350-355. e2, 2015
The emerging importance of IgG Fab glycosylation in immunity
FS van de Bovenkamp, L Hafkenscheid, T Rispens, Y Rombouts
The Journal of Immunology 196 (4), 1435-1441, 2016
Detection of infliximab levels and anti‐infliximab antibodies: a comparison of three different assays
N Vande Casteele, DJ Buurman, MGG Sturkenboom, JH Kleibeuker, ...
Alimentary pharmacology & therapeutics 36 (8), 765-771, 2012
Decoding the human immunoglobulin G-glycan repertoire reveals a spectrum of Fc-receptor-and complement-mediated-effector activities
G Dekkers, L Treffers, R Plomp, AEH Bentlage, M de Boer, ...
Frontiers in immunology 8, 877, 2017
Key findings towards optimising adalimumab treatment: the concentration–effect curve
MF Pouw, CL Krieckaert, MT Nurmohamed, D van der Kleij, L Aarden, ...
Annals of the rheumatic diseases 74 (3), 513-518, 2015
Adalimumab elicits a restricted anti-idiotypic antibody response in autoimmune patients resulting in functional neutralisation
PA van Schouwenburg, LA van de Stadt, RN de Jong, EEL van Buren, ...
Annals of the rheumatic diseases 72 (1), 104-109, 2013
Differential effect of drug interference in immunogenicity assays
MH Hart, H de Vrieze, D Wouters, GJ Wolbink, J Killestein, ER de Groot, ...
Journal of immunological methods 372 (1-2), 196-203, 2011
Extensive glycosylation of ACPA-IgG variable domains modulates binding to citrullinated antigens in rheumatoid arthritis
Y Rombouts, A Willemze, JJBC van Beers, J Shi, PF Kerkman, ...
Annals of the rheumatic diseases 75 (3), 578-585, 2016
Pharmacokinetic features and presence of antidrug antibodies associate with response to infliximab induction therapy in patients with moderate to severe ulcerative colitis
JF Brandse, RA Mathôt, D van der Kleij, T Rispens, Y Ashruf, JM Jansen, ...
Clinical Gastroenterology and Hepatology 14 (2), 251-258. e2, 2016
A prominent lack of IgG1-Fc fucosylation of platelet alloantibodies in pregnancy
R Kapur, I Kustiawan, A Vestrheim, CAM Koeleman, R Visser, ...
Blood, The Journal of the American Society of Hematology 123 (4), 471-480, 2014
Mechanism of immunoglobulin G4 Fab-arm exchange
T Rispens, P Ooijevaar-de Heer, O Bende, RC Aalberse
Journal of the American Chemical Society 133 (26), 10302-10311, 2011
Afucosylated IgG characterizes enveloped viral responses and correlates with COVID-19 severity
MD Larsen, EL de Graaf, ME Sonneveld, HR Plomp, J Nouta, W Hoepel, ...
Science 371 (6532), eabc8378, 2021
Fc gamma receptor-TLR cross-talk elicits pro-inflammatory cytokine production by human M2 macrophages
LTC Vogelpoel, IS Hansen, T Rispens, FJM Muller, TMM Van Capel, ...
Nature communications 5 (1), 1-8, 2014
Enrichment of sialylated IgG by lectin fractionation does not enhance the efficacy of immunoglobulin G in a murine model of immune thrombocytopenia
T Guhr, J Bloem, NIL Derksen, M Wuhrer, AHL Koenderman, RC Aalberse, ...
PloS one 6 (6), e21246, 2011
Human IgG4 binds to IgG4 and conformationally altered IgG1 via Fc-Fc interactions
T Rispens, P Ooievaar-De Heer, E Vermeulen, J Schuurman, ...
The Journal of Immunology 182 (7), 4275-4281, 2009
Beyond citrullination: other post-translational protein modifications in rheumatoid arthritis
LA Trouw, T Rispens, REM Toes
Nature Reviews Rheumatology 13 (6), 331-339, 2017
Clinical relevance of serum natalizumab concentration and anti-natalizumab antibodies in multiple sclerosis
A Vennegoor, T Rispens, EMM Strijbis, A Seewann, BMJ Uitdehaag, ...
Multiple Sclerosis Journal 19 (5), 593-600, 2013
The system can't perform the operation now. Try again later.
Articles 1–20